Association between solar insolation and a history of suicide attempts in bipolar I disorder.


Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
06 2019
Historique:
received: 12 10 2018
revised: 05 02 2019
accepted: 01 03 2019
pubmed: 18 3 2019
medline: 2 7 2020
entrez: 18 3 2019
Statut: ppublish

Résumé

In many international studies, rates of completed suicide and suicide attempts have a seasonal pattern that peaks in spring or summer. This exploratory study investigated the association between solar insolation and a history of suicide attempt in patients with bipolar I disorder. Solar insolation is the amount of electromagnetic energy from the Sun striking a surface area on Earth. Data were collected previously from 5536 patients with bipolar I disorder at 50 collection sites in 32 countries at a wide range of latitudes in both hemispheres. Suicide related data were available for 3365 patients from 310 onset locations in 51 countries. 1047 (31.1%) had a history of suicide attempt. There was a significant inverse association between a history of suicide attempt and the ratio of mean winter solar insolation/mean summer solar insolation. This ratio is smallest near the poles where the winter insolation is very small compared to the summer insolation. This ratio is largest near the equator where there is relatively little variation in the insolation over the year. Other variables in the model that were positively associated with suicide attempt were being female, a history of alcohol or substance abuse, and being in a younger birth cohort. Living in a country with a state-sponsored religion decreased the association. (All estimated coefficients p < 0.01). In summary, living in locations with large changes in solar insolation between winter and summer may be associated with increased suicide attempts in patients with bipolar disorder. Further investigation of the impacts of solar insolation on the course of bipolar disorder is needed.

Identifiants

pubmed: 30878786
pii: S0022-3956(18)31214-7
doi: 10.1016/j.jpsychires.2019.03.001
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Michael Bauer (M)

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Electronic address: michael.bauer@uniklinikum-dresden.de.

Tasha Glenn (T)

ChronoRecord Association, Fullerton, CA, USA.

Martin Alda (M)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Ole A Andreassen (OA)

NORMENT - K.G. Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Elias Angelopoulos (E)

Department of Psychiatry, National and Capodistrian University of Athens, Medical School, Eginition Hospital, Athens, Greece.

Raffaella Ardau (R)

Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy.

Yavuz Ayhan (Y)

Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Christopher Baethge (C)

Department of Psychiatry and Psychotherapy, University of Cologne Medical School, Cologne, Germany.

Rita Bauer (R)

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Bernhard T Baune (BT)

Department of Psychiatry, School of Medicine, University of Adelaide, Adelaide, Australia.

Claudia Becerra-Palars (C)

National Institute of Psychiatry '"Ramón de la Fuente Muñiz", Mexico City, Mexico.

Frank Bellivier (F)

Psychiatry and Addiction Medicine. Assistance Publique - Hôpitaux de Paris, INSERM UMR-S1144, Denis Diderot University, René Descartes University, FondaMental Foundation, Paris, France.

Robert H Belmaker (RH)

Department of Psychiatry, Faculty of Health Sciences, Beer Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel.

Michael Berk (M)

Deakin University, IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Geelong, Victoria, Australia; Department of Psychiatry, Orygen, the National Centre for Excellence in Youth Mental Health, the Centre for Youth Mental Health and the Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.

Yuly Bersudsky (Y)

Department of Psychiatry, Faculty of Health Sciences, Beer Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel.

Şule Bicakci (Ş)

Van Research and Training Hospital, Van, Turkey.

Harriet Birabwa-Oketcho (H)

Butabika Hospital, Kampala, Uganda.

Thomas D Bjella (TD)

NORMENT - K.G. Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Jorge Cabrera (J)

Mood Disorders Clinic, Dr. Jose Horwitz Psychiatric Institute, Santiago de Chile, Chile.

Eric Y Wo Cheung (EY)

Department of General Adult Psychiatry, Castle Peak Hospital, Hong Kong.

Maria Del Zompo (M)

Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy.

Seetal Dodd (S)

Deakin University, IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Geelong, Victoria, Australia; Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia.

Markus Donix (M)

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Bruno Etain (B)

Psychiatry and Addiction Medicine. Assistance Publique - Hôpitaux de Paris, INSERM UMR-S1144, Denis Diderot University, René Descartes University, FondaMental Foundation, Paris, France.

Andrea Fagiolini (A)

Department of Molecular Medicine and Department of Mental Health (DAI), University of Siena and University of Siena Medical Center (AOUS), Siena, Italy.

Kostas N Fountoulakis (KN)

Division of Neurosciences, 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Mark A Frye (MA)

Department of Psychiatry & Psychology, Mayo Clinic Depression Center, Mayo Clinic, Rochester, MN, USA.

Ana Gonzalez-Pinto (A)

Department of Psychiatry, University Hospital of Alava, University of the Basque Country, CIBERSAM, Vitoria, Spain.

John F Gottlieb (JF)

Department of Psychiatry, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Paul Grof (P)

Mood Disorders Center of Ottawa, University of Toronto, Toronto, ON, Canada.

Hirohiko Harima (H)

Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Setagaya, Tokyo, Japan.

Chantal Henry (C)

AP-HP, Hopitaux Universitaires Henri Mondor and INSERM U955 (IMRB) and Université Paris Est and Institut Pasteur, Unité Perception et Mémoire, Paris, France.

Erkki T Isometsä (ET)

Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; National Institute for Health and Welfare, Helsinki, Finland.

Sven Janno (S)

Department of Psychiatry, University of Tartu, Tartu, Estonia.

Flávio Kapczinski (F)

Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Mathias Kardell (M)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Slim Khaldi (S)

Private practice, Tunis, Tunisia.

Sebastian Kliwicki (S)

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.

Barbara König (B)

BIPOLAR Zentrum Wiener Neustadt, Wiener Neustadt, Austria.

Timur L Kot (TL)

Khanty-Mansiysk Clinical Psychoneurological Hospital, Khanty-Mansiysk, Russia.

Rikke Krogh (R)

Department of Affective Disorders, Q, Mood Disorders Research Unit, Aarhus University Hospital, Aarhus, Denmark.

Mauricio Kunz (M)

Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Beny Lafer (B)

Bipolar Disorder Research Program, Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.

Mikael Landén (M)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.

Erik R Larsen (ER)

Department of Affective Disorders, Q, Mood Disorders Research Unit, Aarhus University Hospital, Aarhus, Denmark.

Ute Lewitzka (U)

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Rasmus W Licht (RW)

Unit for Psychiatric Research, Aalborg University Hospital, Psychiatry, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Carlos Lopez-Jaramillo (C)

Mood Disorders Program, Hospital Universitario San Vicente Fundación, Research Group in Psychiatry, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.

Glenda MacQueen (G)

Department of Psychiatry, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.

Mirko Manchia (M)

Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada; Section of Psychiatry, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.

Wendy Marsh (W)

Department of Psychiatry, University of Massachusetts, Worcester, MA, USA.

Mónica Martinez-Cengotitabengoa (M)

Department of Psychiatry, University Hospital of Alava, University of the Basque Country, CIBERSAM, Vitoria, Spain.

Ingrid Melle (I)

NORMENT - K.G. Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Fátima Meza-Urzúa (F)

National Institute of Psychiatry '"Ramón de la Fuente Muñiz", Mexico City, Mexico.

Mok Yee Ming (MY)

Department of General Psychiatry, Mood Disorders Unit, Institute of Mental Health, Singapore City, Singapore.

Scott Monteith (S)

Michigan State University College of Human Medicine, Traverse City Campus, Traverse City, MI, USA.

Gunnar Morken (G)

Department of Mental Health, Norwegian University of Science and Technology - NTNU, Trondheim, Norway; Department of Psychiatry, St Olavs' University Hospital, Trondheim, Norway.

Enrica Mosca (E)

Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy.

Anton A Mozzhegorov (AA)

Soviet Psychoneurological Hospital, Urai, Russia.

Rodrigo Munoz (R)

Department of Psychiatry, University of California San Diego, San Diego, CA, USA.

Starlin V Mythri (SV)

Asha Bipolar Clinic, Asha Hospital, Hyderabad, Telangana, India.

Fethi Nacef (F)

Razi Hospital, Faculty of Medicine, University of Tunis-El Manar, Tunis, Tunisia.

Ravi K Nadella (RK)

Department of Psychiatry, NIMHANS, Bangalore, India.

Fabiano G Nery (FG)

Bipolar Disorder Research Program, Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.

René E Nielsen (RE)

Unit for Psychiatric Research, Aalborg University Hospital, Psychiatry, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Claire O'Donovan (C)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Adel Omrani (A)

Tunisian Bipolar Forum, Érable Médical Cabinet 324, Lac 2, Tunis, Tunisia.

Yamima Osher (Y)

Department of Psychiatry, Faculty of Health Sciences, Beer Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel.

Helle Østermark Sørensen (HØ)

Unit for Psychiatric Research, Aalborg University Hospital, Psychiatry, Aalborg, Denmark.

Uta Ouali (U)

Razi Hospital, Faculty of Medicine, University of Tunis-El Manar, Tunis, Tunisia.

Yolanda Pica Ruiz (YP)

Hospital "Ángeles del Pedregal", Mexico City, Mexico.

Maximilian Pilhatsch (M)

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Marco Pinna (M)

Lucio Bini Mood Disorder Center, Cagliari, Italy.

Francisco D R da Ponte (FDR)

Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Danilo Quiroz (D)

Deparment of Psychiatry, Diego Portales University, Santiago de Chile, Chile.

Raj Ramesar (R)

UCT/MRC Human Genetics Research Unit, Division of Human Genetics, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Natalie Rasgon (N)

Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Palo Alto, CA, USA.

M S Reddy (MS)

Asha Bipolar Clinic, Asha Hospital, Hyderabad, Telangana, India.

Andreas Reif (A)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany.

Philipp Ritter (P)

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Janusz K Rybakowski (JK)

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.

Kemal Sagduyu (K)

Department of Psychiatry, University of Missouri Kansas City School of Medicine, Kansas City, MO, USA.

Bharathram Sathur Raghuraman (BS)

Department of Psychiatry, NIMHANS, Bangalore, India.

Ângela M Scippa (ÂM)

Department of Neuroscience and Mental Health, Federal University of Bahia, Salvador, Brazil.

Emanuel Severus (E)

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Christian Simhandl (C)

BIPOLAR Zentrum Wiener Neustadt, Wiener Neustadt, Austria.

Paul W Stackhouse (PW)

Science Directorate/Climate Science Branch, NASA Langley Research Center, Hampton, VA, USA.

Dan J Stein (DJ)

Department of Psychiatry, MRC Unit on Risk & Resilience in Mental Disorders, University of Cape Town, Cape Town, South Africa.

Sergio Strejilevich (S)

Bipolar Disorder Program, Neuroscience Institute, Favaloro University, Buenos Aires, Argentina.

Mythily Subramaniam (M)

Research Division, Institute of Mental Health, Singapore.

Ahmad Hatim Sulaiman (AH)

Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Kirsi Suominen (K)

Department of Social Services and Health Care, Psychiatry, City of Helsinki, Finland.

Hiromi Tagata (H)

Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Setagaya, Tokyo, Japan.

Yoshitaka Tatebayashi (Y)

Schizophrenia & Affective Disorders Research Project, Tokyo Metropolitan Institute of Medical Science, Seatagaya, Tokyo, Japan.

Leonardo Tondo (L)

McLean Hospital-Harvard Medical School, Boston, MA, USA; Mood Disorder Lucio Bini Centers, Cagliari e Roma, Italy.

Carla Torrent (C)

Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.

Arne E Vaaler (AE)

Department of Mental Health, Norwegian University of Science and Technology - NTNU, Trondheim, Norway; Department of Psychiatry, St Olavs' University Hospital, Trondheim, Norway.

Edgar Vares (E)

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Julia Veeh (J)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany.

Eduard Vieta (E)

Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.

Biju Viswanath (B)

Department of Psychiatry, NIMHANS, Bangalore, India.

Maria Yoldi-Negrete (M)

Consejo Nacional de Ciencia y Tecnología - Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico.

Mark Zetin (M)

Department of Psychology, Chapman University, Orange, CA, USA.

Yosra Zgueb (Y)

Razi Hospital, Faculty of Medicine, University of Tunis-El Manar, Tunis, Tunisia.

Peter C Whybrow (PC)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles (UCLA), Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH